We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Health body’s concern reflects heightened vigilance over signs of disease outbreaks since Covid pandemic
Vaccine recipient claims he suffered side effect of severe blood clot
Claimants previously assessed as too sick for a job worried they could be told to work from home
German group says prospective blockbuster asundexian failed to demonstrate efficacy
Also in this newsletter: Why tourists and residents are fighting over Rome’s sidewalks
A new crop of weight-loss drugs is disrupting markets as well as transforming waistlines
In any conflict situation, from Gaza to Ukraine, medical staff must be protected and given unhindered access to patients
Royal College of GPs urges government to take action over ‘unsafe’ infrastructure ahead of Autumn Statement
In the age of the like, the share and the overshare, enjoy the quiet glee of hanging on to good news
Chancellor to announce plans to tackle long-term sickness and joblessness in Autumn Statement next week
Study shows potential of technology to improve and speed up medical diagnoses
Regulator authorises treatment for sickle cell disease and beta thalassaemia
Why it may be time to ditch the apps and meditation zones — plus the Office Therapy advice column
T-Therapeutics hopes to use genetically engineered rodents and machine learning to discover drugs
Anjana Ahuja selects her must-read titles
Covid may have abated, but emerging diseases and new drug categories are keeping the analytics firm busy
NHS Providers chief warns of ‘sense of dread’ among staff ahead of winter as union remains locked in pay dispute
With real meat facing real problems, investors should cut back their exposure
Can’t find space for your home workout? The Pivot is here to help
Wegovy found to have ‘quite profound’ effect on reducing risk of heart attacks, says pharma group
For many, resuming normal life is a desecration, an abandonment of the hostages and the dead
NAO says just £729mn from original £1.7bn budget may now be spent between 2022 and 2025
Anglo-Swedish drugmaker’s oncology and rare disease medication sales offset waning demand for Covid jabs
Sarah Meredith was in urgent need of a liver when she found out an algorithm would be making the life-or-death decision
US and UK regulators say diabetes medication showed ‘significant’ weight loss benefits
International Edition
